Invesco
CPRX icon

Invesco’s Catalyst Pharmaceutical CPRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$26.3M Buy
1,213,700
+14,073
+1% +$305K ﹤0.01% 1307
2025
Q1
$29.1M Buy
1,199,627
+352,776
+42% +$8.55M 0.01% 1261
2024
Q4
$17.7M Sell
846,851
-92,675
-10% -$1.93M ﹤0.01% 1551
2024
Q3
$18.7M Buy
939,526
+100,071
+12% +$1.99M ﹤0.01% 1493
2024
Q2
$13M Sell
839,455
-154,603
-16% -$2.39M ﹤0.01% 1651
2024
Q1
$15.8M Buy
994,058
+74,411
+8% +$1.19M ﹤0.01% 1562
2023
Q4
$15.5M Sell
919,647
-107,954
-11% -$1.81M ﹤0.01% 1555
2023
Q3
$12M Sell
1,027,601
-197,013
-16% -$2.3M ﹤0.01% 1636
2023
Q2
$16.5M Buy
1,224,614
+89,766
+8% +$1.21M ﹤0.01% 1472
2023
Q1
$18.8M Sell
1,134,848
-303,353
-21% -$5.03M 0.01% 1385
2022
Q4
$26.8M Sell
1,438,201
-42,708
-3% -$794K 0.01% 1223
2022
Q3
$19M Buy
1,480,909
+527,647
+55% +$6.77M 0.01% 1347
2022
Q2
$6.68M Buy
953,262
+479,765
+101% +$3.36M ﹤0.01% 2117
2022
Q1
$3.93M Buy
473,497
+437,247
+1,206% +$3.62M ﹤0.01% 2483
2021
Q4
$245K Sell
36,250
-3,231
-8% -$21.8K ﹤0.01% 3666
2021
Q3
$209K Buy
39,481
+5,119
+15% +$27.1K ﹤0.01% 3749
2021
Q2
$198K Buy
34,362
+3,257
+10% +$18.8K ﹤0.01% 3764
2021
Q1
$143K Sell
31,105
-4,515
-13% -$20.8K ﹤0.01% 3696
2020
Q4
$119K Buy
35,620
+7,304
+26% +$24.4K ﹤0.01% 3579
2020
Q3
$84K Sell
28,316
-13,594
-32% -$40.3K ﹤0.01% 3545
2020
Q2
$194K Buy
41,910
+12,926
+45% +$59.8K ﹤0.01% 3446
2020
Q1
$111K Buy
28,984
+8,311
+40% +$31.8K ﹤0.01% 3510
2019
Q4
$77K Sell
20,673
-373,673
-95% -$1.39M ﹤0.01% 3567
2019
Q3
$2.09M Buy
+394,346
New +$2.09M ﹤0.01% 2600
2019
Q1
Sell
-25,652
Closed -$49K 3673
2018
Q4
$49K Sell
25,652
-946
-4% -$1.81K ﹤0.01% 3657
2018
Q3
$101K Sell
26,598
-1,960
-7% -$7.44K ﹤0.01% 3736
2018
Q2
$89K Buy
+28,558
New +$89K ﹤0.01% 3746
2016
Q1
Sell
-413,770
Closed -$1.01M 3682
2015
Q4
$1.01M Buy
413,770
+1,017
+0.2% +$2.49K ﹤0.01% 2933
2015
Q3
$1.24M Buy
412,753
+411,371
+29,766% +$1.23M ﹤0.01% 2793
2015
Q2
$6K Buy
+1,382
New +$6K ﹤0.01% 4110
2014
Q3
Sell
-67,393
Closed -$171K 4100
2014
Q2
$171K Buy
+67,393
New +$171K ﹤0.01% 3766